Cardiovascular death showed a 29% reduction compared with the placebo group
Edelstein A, Amodaj N, Hoover K, Vale R, Stuurman N
The Tricomin studies used specific formulations that aren't directly comparable to DIY serums assembled from peptide suppliers
Advertisement Advertisement Patients may benefit from booster appointments, psychological support Researchers explore how changes in the gut microbiome influence the brain's reward response to alcohol Retrospective study highlights psychosocial predictors of bariatric surgery outcomes Comprehensive mental health screening may help prevent postsurgical risks Consider each patient's unique disease progression and treatment goals when choosing a strategy Sustained weight loss helps reduce IIH symptoms and medication dependence Findings could help identify patients at risk for poor outcomes Findings show greater reduction in CKD progression, kidney failure than GLP-1RAs
Iron and liver cancer: an inseparable connection
In large obesity trials, incident high blood pressure occurred in fewer than 1% of semaglutide users versus about 2% on placebo, suggesting no clear causal link
